Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Bethesda, MD
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Boston, MA
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Worcester, MA
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Worcester, MA
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Ann Arbor, MI
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Flint, MI
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Flint, MI
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Kansas City, MO
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Kansas City, MO
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Reno, NV
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Reno, NV
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Albuquerque, NM
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Bethpage, NY
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Bethpage, NY
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Huntington Station, NY
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Huntington Station, NY
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Jamaica, NY
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Jamaica, NY
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Chapel Hill, NC
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Charlotte, NC
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Durham, NC
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Durham, NC
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Hendersonville, NC
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Hendersonville, NC
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Raleigh, NC
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Winston-Salem, NC
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Bismarck, ND
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Bismarck, ND
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Canton, OH
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Canton, OH
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Middletown, OH
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Middletown, OH
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Portland, OR
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Nashville, TN
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Amarillo, TX
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Amarillo, TX
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Houston, TX
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Webster, TX
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Webster, TX
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Norfolk, VA
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Portsmouth, VA
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Portsmouth, VA
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Richmond, VA
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Richmond, VA
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Tacoma, WA
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Milwaukee, WI
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Capital Federal,
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Capital Federal,
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Washington, D.C.,
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Saint Louis Park, MN
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Saint Louis, MO
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Birmingham, AL
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Huntsville, AL
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Huntsville, AL
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Mobile, AL
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Mobile, AL
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Muscle Shoals, AL
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Muscle Shoals, AL
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Northport, AL
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Northport, AL
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Glendale, AZ
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Glendale, AZ
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Phoenix, AZ
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Scottsdale, AZ
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Sun City, AZ
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Sun City, AZ
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Tempe, AZ
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Tempe, AZ
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Tucson, AZ
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Hot Springs, AR
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Hot Springs, AR
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Little Rock, AR
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Anaheim, CA
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Bakersfield, CA
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Beverly Hills, CA
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Beverly Hills, CA
Click here to add this to my saved trials